Sign Up Today and Learn More About DocMeIn Stock
Invest in or calculate the value of your shares in DocMeIn or other pre-IPO companies through EquityZen's platform.
DocMeIn Stock (DOIN)
Online appointment management for Doctors
About DocMeIn Stock
Founded
2009
Industries
Software, Artificial Intelligence, Data and Analytics
[DocMeIn](http://www.docmein.com/) is a free online appointment management service for group and solo medical practices. DocMeIn includes intelligent appointment scheduling, unlimited email reminders, continuing care reminders (recalls) and patient self-service. DocMeIn's key differentiators are: - zero cost, ad free, unlimited use; - intuitive and visually appealing user experience; - tailored configurations for specific verticals. DocMeIn is also a platform powering several branded scheduling solutions in various verticals and geographies. The white-label platform can be customized and localized by partners, who can also integrate it into their existing properties (such as provider directories, daily deals sites, etc) and with their small-business packaged software. The partners then generate incremental revenue from their existing client base through the DocMeIn platform.
DocMeIn Management
Leadership team at DocMeIn
Founder
Andrey Svrisky
Co-Founder
Daniel Feygin
Join now and verify your accreditation status to gain access to:
- DocMeIn Current Valuation
- DocMeIn Stock Price
- DocMeIn Management
- Available deals in DocMeIn and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- DocMeIn Cap Table and Funding History by Share Class and Liquidity Preferences
- DocMeIn Revenue and Financials
- DocMeIn Highlights
- DocMeIn Business Model
- DocMeIn Risk Factors
- DocMeIn Research Report from SACRA Research
Trading DocMeIn Stock
How to invest in DocMeIn stock?
Accredited investors can buy pre-IPO stock in companies like DocMeIn through EquityZen funds. These investments are made available by existing DocMeIn shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell DocMeIn stock?
Shareholders can sell their DocMeIn stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
